Oracle (NYSE:ORCL) Stock Falls 8.8% – Here’s What Happened

Oracle Corporation (NYSE:ORCL – Get Free Report) shares fell 8.8% during trading on Wednesday. The company traded as low as $129.23 and last traded at $130.60. 50,478,215 shares were traded during trading, an increase of 71% from the average session volume of 29,451,123 shares. The stock had previously closed at $143.20.

Trending Headlines about Oracle

Here are the key news stories impacting Oracle this week:

  • Positive Sentiment: Mizuho reaffirmed an Outperform rating and a $320 price target, arguing that Oracle’s long-term growth opportunity remains attractive despite regulatory and infrastructure challenges. Wall Street analyst updates Oracle stock price target
  • Positive Sentiment: Oracle’s cloud and AI demand outlook remains a key support, with approximately $664 billion in remaining performance obligations. Analysts also continue to view the company as a strong growth stock. Will Rising Capex Weigh on Oracle’s Free Cash Flow Outlook?
  • Positive Sentiment: Oracle reaffirmed Bloom Energy’s role in Project Jupiter and proposed an electricity arrangement intended to support the New Mexico AI data-center campus, reinforcing its commitment to expanding capacity.
  • Neutral Sentiment: Oracle is urging federal regulators to expedite approval of the 17.8-mile Green Chile natural-gas pipeline, which would supply Project Jupiter. The request highlights the project’s scale but also underscores its dependence on regulatory approvals and energy infrastructure. Oracle urges regulators to speed up pipeline approval
  • Negative Sentiment: Investors remain concerned that Project Jupiter could be delayed because of uncertainty around pipeline approval. The issue is weighing more heavily than the reiterated buy ratings and ambitious price targets. Oracle Stock Tumbles: What’s Going On?
  • Negative Sentiment: Rapid AI infrastructure spending is pushing free cash flow negative and raising concerns about leverage, capital intensity and whether future cloud profits will justify the investment. Why Did Oracle Stock Drop Today?
  • Negative Sentiment: A law firm is investigating potential customer claims tied to an alleged Oracle Health data breach, creating an additional legal and reputational risk, although the financial impact remains uncertain. Oracle Health Data Breach Investigation

Analysts Set New Price Targets

Several analysts recently weighed in on ORCL shares. Guggenheim reiterated a “buy” rating and issued a $400.00 price objective (up from $375.00) on shares of Oracle in a research report on Tuesday, September 8th. TD Cowen restated a “buy” rating and issued a $240.00 price target (down from $300.00) on shares of Oracle in a research note on Wednesday, September 9th. Barclays lifted their price target on Oracle from $250.00 to $252.00 and gave the company an “overweight” rating in a report on Friday, September 11th. UBS Group increased their price objective on Oracle from $245.00 to $250.00 and gave the stock a “buy” rating in a report on Friday, September 11th. Finally, BMO Capital Markets cut their target price on Oracle from $220.00 to $195.00 and set an “outperform” rating on the stock in a research note on Friday, September 11th. One research analyst has rated the stock with a Strong Buy rating, thirty-six have assigned a Buy rating, nine have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $251.72.

Read Our Latest Research Report on ORCL

Oracle Price Performance

The firm has a market capitalization of $394.90 billion, a P/E ratio of 20.47, a P/E/G ratio of 0.97 and a beta of 1.78. The business’s fifty day moving average is $146.20 and its 200 day moving average is $158.98. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 1.89.

Oracle (NYSE:ORCL – Get Free Report) last released its quarterly earnings data on Thursday, September 10th. The enterprise software provider reported $1.92 earnings per share for the quarter, topping the consensus estimate of $1.74 by $0.18. Oracle had a return on equity of 48.85% and a net margin of 26.36%. The business had revenue of $19.34 billion during the quarter, compared to analyst estimates of $19.13 billion. During the same period last year, the company posted $1.47 EPS. The company’s revenue was up 29.6% compared to the same quarter last year. Oracle has set its Q2 2027 guidance at 1.850-1.930 EPS and its FY 2027 guidance at 8.100-8.100 EPS. As a group, analysts forecast that Oracle Corporation will post 6.69 EPS for the current year.

Oracle Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 23rd. Shareholders of record on Friday, October 9th will be paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 1.5%. The ex-dividend date of this dividend is Friday, October 9th. Oracle’s payout ratio is 31.35%.

Insider Buying and Selling

In other Oracle news, EVP Maria Smith sold 2,631 shares of the stock in a transaction that occurred on Tuesday, September 22nd. The shares were sold at an average price of $151.70, for a total value of $399,122.70. Following the completion of the sale, the executive vice president owned 64,357 shares in the company, valued at $9,762,956.90. This represents a 3.93% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Michael D. Sicilia sold 22,562 shares of Oracle stock in a transaction on Tuesday, September 22nd. The shares were sold at an average price of $151.59, for a total transaction of $3,420,173.58. Following the sale, the chief executive officer directly owned 182,929 shares of the company’s stock, valued at $27,730,207.11. This trade represents a 10.98% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 36,075 shares of company stock worth $5,342,123. 38.40% of the stock is owned by company insiders.

Institutional Investors Weigh In On Oracle

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Basso Capital Management L.P. purchased a new position in Oracle in the fourth quarter worth $29,000. Maseco LLP purchased a new stake in shares of Oracle during the 1st quarter valued at $29,000. Persistent Asset Partners Ltd purchased a new stake in shares of Oracle during the 2nd quarter valued at $29,000. North Point Portfolio Managers Corp OH bought a new stake in shares of Oracle during the 3rd quarter worth $27,000. Finally, Markowski Investments purchased a new position in shares of Oracle in the 2nd quarter worth about $32,000. 42.44% of the stock is owned by hedge funds and other institutional investors.

Oracle Company Profile

(Get Free Report)

Oracle Corporation (NYSE: ORCL) is a global technology company that develops enterprise software, cloud services and related hardware. Its offerings help businesses manage databases, applications, data, infrastructure and other core information-technology operations.

The company is best known for its Oracle Database, along with cloud-based infrastructure and platform services. Oracle also provides enterprise applications for functions such as finance, human resources, supply-chain management, customer experience and industry-specific operations.

Featured Articles

Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.